The San Diego Circuit libraries (Circuit), a consortium of six prominent academic and public libraries, has announced the availability of a campaign website designed to help community members identify and protect themselves from health misinformation.
UC San Diego researchers report that a late-stage, pre-clinical small molecule inhibitor reverses malignant hyper-editing by a protein that promotes silencing of the immune response, metastasis and therapeutic resistance in 20 different cancer types.
“The pandemic highlighted an underserved area—rapid detection of various different pathogens such as COVID, the flu, and other viruses,” says Shane Bowen '00, '05, a co-founder of Palamedrix.
With a generous $22 million in gifts from Joan and Irwin Jacobs, UC San Diego Health will bring its Center for Health Innovation into full reality.
Toddlers’ level of attention to "motherese" speech can be used as a biomarker for autism spectrum disorder (ASD). UC San Diego scientists developed a new eye-tracking test to measure it, which can accurately identify toddlers with a subtype of ASD.
A novel drug combination for leukemia, pioneered at UC San Diego Health, provides patients with a better treatment option that results in less side effects and can put patients in remission.
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.
